Catalyst Wire Dossier Catalyst Wire Dossier

PG101

· Rhodes Pharmaceuticals, L.P.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PG101, covering 2014-03-05 to 2014-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of PG101 for Dry Eye Syndrome [Phase 1, Phase 2]

See pricing